Pharmaceutical Plastic Packaging Market

The Pharmaceutical Plastic Packaging Market is valued at USD 38.9 Bn in 2026 and is projected to reach USD 97.9 Bn, growing at a CAGR of 14% by 2033.

Market Analysis Brief

The global pharmaceutical plastic packaging market size is all set for tremendous growth in the years to come, which is majorly attributed to the burgeoning expansion of the pharmaceutical industry. Furthermore, the massive growth of the pharmaceutical business due to the rise in chronic diseases such as cancer, diabetes, and cardiovascular diseases is extending the growth ambits of the market. The ongoing technological and scientific development shall further fuel the growth of the global market. Anticipating these trends, the coming years shall create positive tides for the global pharmaceutical plastic packaging industry.

Key Report Findings

• The global pharmaceutical plastic packaging market has crossed
• Rapid technological advances hold immense potential to drive market expansion
• The plastic bottles segment is likely to emerge as the leading segment owing to its shatter resistance, moldability and greater strength
• North America to consolidate a strong foothold in the global pharmaceutical plastic packaging market
• Amcor plc, Becton, Dickinson and Company, AptarGroup, Inc., and Drug Plastics Group are some of the leaders in the pharmaceutical plastic packaging industry

Growth Drivers

Cutting-edge Technological Advancements

Nano-drug delivery systems leverage advanced technologies that utilise nanoparticles, ensuring the targeted delivery and controlled release of therapeutic agents. This modern technology, in its development stage, can be potentially used in treatment for cancer, cardiovascular diseases, diabetes, and various microbial and inflammatory diseases. In addition, nanotechnology provides various benefits during the treatment of chronic ailments such as cardiovascular diseases (CVDs). This is facilitated by site-specific and target-oriented delivery of drugs.

To avert the risk of children handling, opening, and ingesting dangerous items, child-resistant packaging (CRP) is extensively used. Regulatory compliance for prescription drugs, nicotine-based products, and over-the-counter medications is a critical enabler of the scaled adoption of CRP. Various developed countries have mandated the use of CRP for drugs such as aspirin, contraceptive pills, paracetamol, elemental iron, and others. This complements the growth of the pharmaceutical plastic packaging market to a large extent.

Accentuation on Primary Pharmaceutical Packaging

Primary pharmaceutical packaging solutions are regarded as products that come in immediate contact with medicine or drugs. Plastic bottles, prefilled syringes, glass bottles, pre-filled inhalers, blister packaging, and medication tubes among others are a few types of packaging options available in the market. The global pharmaceutical plastic packaging market is majorly driven by the growing demand for pre-fillable syringes and pre-fillable inhalers.

Moreover, blister packs, plastic bottles, and ampoules and vials are a few prominent primary pharmaceutical packaging that is growing at breakneck speed. During the forecast period, innovations in biotechnology responsible for the development of new injectable parenteral therapies and accelerated demand for high visibility unit dosage packaging for diseases including diabetes shall nurture a strong base for the global market, generating substantial business opportunities for market players.

Plastics Remains an Ideal Raw Material

Considering the type of raw material used, plastic paces ahead of the competition in the pharmaceutical plastic packaging market owing to design flexibility and greater affordability of the packaging solution. This makes it a perfect fit for pharmaceutical packaging. The material stands out due to its impeccable properties including rigidity, strength, shatter resistance, moldability, and light-weighting.

The superior shatter resistance makes it suitable for transportation and provides ease of handling goods during the transition. The ease of moulding offered by plastic further adds the strength and efficiency necessary for shielding in vapour, and gas.

Overview of Key Segments

Plastic Bottles Segment Holds a Major Market Share

The most popular type of packaging item for packaging pharmaceuticals is plastic bottles. These types of packaging items are ideal for storing drugs in liquid and solid forms. Based on certain applications, these plastic bottles can be aligned with an apt type of cap and closure nasal, for instance, nasal spray, and ophthalmic drops.

Various types of packaging relevant to plastic bottles include sterile packaging for blood and related components, rigid form for solid dosages, squeezable bottles, and jars. With more patient compliance and convenience with oral drug delivery, the growing pervasiveness of communicable diseases, and the rise in the geriatric population in established economies are highlighting the prominence of the plastic bottles segment in the pharmaceutical plastic packaging market.

Nasal Drugs to Spearhead Dominance

Normally, nasal drugs are in liquid form. Yet, it is also available in powder form, offering higher stability and facilitating new device developments, developing a promising growth trajectory. Nasal drug delivery containers are also referred to as nasal sprays. Compression of therapeutically active ingredients dissolved in solutions or mixtures of excipients in non-pressurized dispensers ensures a metered dose of the active ingredient. These doses are either metered by the spray pump or pre-meted during manufacture.

Growth Opportunities Across Regions

North America Reigns Supreme amid Extensive In-house Production

Being a hub for pharma manufacturing, assimilating in-house production as the largest end-use segment, North America is set for boisterous growth. During the period of assessment, the region is likely to lead with an expansive pool of manufacturers of pharmaceutical plastic bottles, satiating the ever-growing demand for pharmaceutical plastic bottles.

On the flip side, Asia Pacific is projected to register the fastest growth attributed to growing awareness among consumers and rising disposable income levels, particularly in China, and India. Heightened government initiatives, expanding pharmaceutical contract manufacturing activities, and a growing geriatric population is expected to promote the pharmaceutical plastic packaging market in the region.

Leading Industry Participants

Some of the most competitive players in the global pharmaceutical plastic packaging market include:

• Amcor plc
• Gerresheimer AG
• AptarGroup, Inc.
• Berry Global Inc.
• West Pharmaceutical Services, Inc.
• CCL Industries Inc.
• Constantia Flexibles Group GmbH
• Sealed Air Corporation
• Sonoco Products Company
• Huhtamaki Oyj
• Alpha Packaging
• Comar LLC
• Drug Plastics Group
• Klöckner Pentaplast
• SCHOTT AG 

Global Pharmaceutical Plastic Packaging Market is Segmented as Below:

By Material:
• Polyethylene
• Polypropylene
• PET
• PVC

By End Use:
• Pharmaceuticals
• Medical Devices
• Biotechnology
• Home Healthcare

By Region:
• Asia Pacific
• Europe
• North America
• Latin America
• Middle East & Africa